Scleroderma (systemic sclerosis) can affect life expectancy differently depending on the type of disease, severity, organ involvement, and response to treatment. Some people have mild symptoms and a near-normal lifespan, while others may develop serious complications affecting major organs.
1. Effect of Scleroderma on Life Expectancy
Life expectancy varies widely:
- Localized scleroderma usually affects the skin and has little impact on lifespan.
- Systemic scleroderma can affect internal organs and may carry greater health risks.
Outcomes have improved over time due to earlier diagnosis, better monitoring, and improved treatments for complications.
2. Disease Type and Severity
✔ Limited Cutaneous Systemic Sclerosis
- Often progresses more slowly.
- Skin involvement is mainly limited to certain areas.
- Some people may develop complications such as pulmonary hypertension or digestive problems.
✔ Diffuse Cutaneous Systemic Sclerosis
- Can progress more quickly.
- May involve larger areas of skin.
- Has a higher risk of internal organ complications, especially early in the disease.
3. Organ Involvement and Long-Term Risks
The organs affected have a major influence on prognosis.
Important complications include:
- Lung disease – scarring or pulmonary hypertension can affect breathing and oxygen levels.
- Heart involvement – inflammation or reduced heart function may increase risks.
- Kidney complications – severe kidney problems can occur in some cases.
- Digestive system issues – swallowing problems, reflux, or reduced intestinal movement may affect nutrition.
Regular screening helps detect complications earlier.
4. Impact of Treatment Advances
Modern care has improved outcomes through:
- Medications that reduce immune system activity
- Treatments that slow lung complications
- Better management of blood pressure and kidney problems
- Improved heart and lung monitoring
- Physical therapy and symptom management
While there is currently no cure, early treatment can reduce complications and improve quality of life.
5. Factors That Influence Long-Term Outcomes
Prognosis may depend on:
- Age at diagnosis
- Type of scleroderma
- Severity of organ involvement
- Response to treatment
- Smoking status
- Overall fitness and health
- Access to specialized medical care
Key Takeaway
Scleroderma’s effect on life expectancy depends largely on whether it is localized or systemic and whether vital organs are affected. People with limited disease may have good long-term outcomes, while those with lung, heart, or kidney involvement may require closer monitoring and treatment. Advances in diagnosis and therapy have significantly improved survival and quality of life for many individuals living with scleroderma.